Concepedia

Publication | Open Access

Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma

DOIFull Paper Access

24

Citations

38

References

2017

Year

Muhamed Baljević, Shadia Zaman, Veerabhadran Baladandayuthapani, Yan Lin, Claudia Morales de Partovi, Zuzana Berkova, Behrang Amini, Sheeba K. Thomas, Jatin J. Shah, Donna M. Weber,
Annals of Hematology

References

YearCitations

Page 1